{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:29:52Z","timestamp":1783531792802,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["739593"],"award-info":[{"award-number":["739593"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Plasma cell enrichment plays a pivotal role in the accurate prognosis and molecular characterization of multiple myeloma. The separation is commonly carried out by positive cell selection using CD138 monoclonal antibody conjugated to magnetic beads. Optimally, during the separation procedure, the cells should neither be damaged, nor should their phenotype be significantly altered, as these changes would falsify the results if the isolated cells were subsequently used. For this reason, we investigated the expression patterns of different surface markers by flow cytometry before and after magnetic isolation using bone marrow or peripheral blood samples from 12 patients with plasma cell disorders. The selected markers are not only used as backbone markers in routine diagnostics (CD19, CD38, CD45, CD117, and CD138), but they also play an important role in cell adhesion and connection with microenvironment (CD44, CD49d, CD56, and CD81) or possibly drug resistance (CD69, CD86, and CD184), making them promising targets for myeloma research. Moreover, we examined the effects of separation on cell viability in 8 cases. The intensities of 8 out of the 12 investigated markers were slightly influenced, while CD138, CD38, CD56, and CD184 were changed significantly, however the immunophenotype of the cells was not changed. Positive markers remained positive and negative ones remained negative after the separation procedure. In addition, the number of apoptotic plasma cells was significantly reduced during separation, facilitating further examination of the cells. Our results showed that magnetic isolation can be considered as a reliable option but the immunophenotype of plasma cells should be validated after the separation if the intensities of the markers are important for further experiments.<\/jats:p>","DOI":"10.3389\/pore.2024.1611882","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:11:21Z","timestamp":1729224681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders"],"prefix":"10.3389","volume":"30","author":[{"given":"\u00c1gnes","family":"Czeti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Sashalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Szal\u00f3ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Kriston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"M\u00e1rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Barna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0022-1759(99)00199-4","article-title":"Isolation and characterization of human multiple myeloma cell enriched populations","volume":"235","author":"Tai","year":"2000","journal-title":"J Immunol Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1751-553X.2012.01433.x","article-title":"Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma","volume":"34","author":"Shin","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bjhh.2016.01.005","article-title":"Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells","volume":"38","author":"Kishimoto","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/sj.onc.1208447","article-title":"Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma","volume":"24","author":"Mattioli","year":"2005","journal-title":"Oncogene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12185-010-0651-4","article-title":"Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting","volume":"92","author":"Cumova","year":"2010","journal-title":"Int J Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","article-title":"A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1","volume":"94","author":"Wijdenes","year":"1996","journal-title":"Br J Haematol"},{"key":"B9","first-page":"18","article-title":"Sample processing and methodological pitfalls in multiple myeloma research","volume":"24","author":"Pot\u00e9\u010dov\u00e1","year":"2011","journal-title":"Klin Onkol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.clml.2020.08.003","article-title":"Impact of CD138 magnetic bead-based positive selection on bone marrow plasma cell surface markers","volume":"21","author":"Bansal","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1182\/blood.v108.11.3516.3516","article-title":"Changes in bone marrow plasma cell surface markers following cd138-magnetic bead based positive selection","volume":"108","author":"Kimlinger","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cyto.b.21265","article-title":"Immunophenotype of normal vs. myeloma plasma cells: toward antibody panel specifications for MRD detection in multiple myeloma","volume":"90","author":"Flores-Montero","year":"2016","journal-title":"Euroflow Cytom B Clin Cytom"},{"key":"B13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1349-7006.1996.tb02108.x","article-title":"Expression of adhesion molecules on myeloma cells","volume":"87","author":"Tatsumi","year":"1996","journal-title":"Jpn J. Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/leu.2013.174","article-title":"Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications","volume":"28","author":"Bjorklund","year":"2014","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/hon.2354","article-title":"The effect of microenvironmental factors on the development of myeloma cells","volume":"35","author":"M\u00e1rk","year":"2017","journal-title":"Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1182\/blood.v126.23.1768.1768","article-title":"CD69 expression predicts favorable outcome in multiple myeloma patients treated with VTD","volume":"126","author":"Buda","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e77608","DOI":"10.1371\/journal.pone.0077608","article-title":"Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma","volume":"8","author":"Stessman","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/1541-7786.MCR-21-0681","article-title":"PDZ proteins SCRIB and DLG1 regulate myeloma cell surface CD86 expression, growth, and survival","volume":"20","author":"Moser-Katz","year":"2022","journal-title":"Mol Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","article-title":"The role of CXCR4 in multiple myeloma: cells\u2019 journey from bone marrow to beyond","volume":"17","author":"Ullah","year":"2019","journal-title":"J Bone Oncol"},{"key":"B20","first-page":"241","article-title":"Plasm cell neoplasms","volume-title":"WHO Classif. tumors Haematop. lymphoid tissues","author":"McKenna","year":"2017"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B22","volume-title":"EasySepTM human WB and BM CD138 positive selection kit II | STEMCELL technologies","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ar.20757","article-title":"Molecular and cellular mechanisms of ectodomain shedding","volume":"293","author":"Hayashida","year":"2010","journal-title":"Anat Rec"},{"key":"B24","first-page":"811","volume-title":"Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase","author":"Fitzgerald","year":"2000"},{"key":"B25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1365-2141.1998.00623.x","article-title":"The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells","volume":"100","author":"Jourdan","year":"1998","journal-title":"Br J Haematol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1182\/blood.v108.11.3442.3442","article-title":"Apoptosis rates in myeloma cells can Be significantly affected by CD138 sorting and by the specific method used to detect apoptotic cells","volume":"108","author":"Kimlinger","year":"2006","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: an immunomodulatory molecule in inflammation and autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front Immunol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2024.1611882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:11:26Z","timestamp":1729224686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2024.1611882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":27,"alternative-id":["10.3389\/pore.2024.1611882"],"URL":"https:\/\/doi.org\/10.3389\/pore.2024.1611882","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"article-number":"1611882"}}